NCT05760612
- Conditions
- Adjuvant Treatment After Trastuzumab, Breast Diseases, Breast Neoplasms, +8 more
- Locations
-
- Sun Yat-sen University Sun Yat-sen Memorial Hospital Guangzhou, China
Clinical trial condition
Neratini
Explore clinical trials studying Neratini. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study